Joint Committee on Vaccination and Immunisation
Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care
The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...
Europe Celebrates the Heart of Healthcare Decision-Making as Laboratory Medicine Professionals Take Centre Stage
Today, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) proudly marks European Laboratory Day, celebrating the professionals at the heart of healthcare decision making. Across Europe, laboratories will...
Bridging the gap: Should pharma step up as public health campaign funding declines?
With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the pharmaceutical industry to step forward and do more to support the nation’s...
UKHSA releases list of pathogens posing ‘greatest risk’ to public health
The agency has listed 24 pathogen families where preparedness efforts are most needed
Making an Impact at the Agents of Change Summit
Medscape Public Health is hitting the road to attend the public health conference Agents of Change. As part of their commitment to making an impact in public health, Medscape is...
Moderna’s JN.1-adapted COVID-19 vaccine approved by MHRA for adults and children
The JCVI has already advised the UK government on eligible groups for this year’s autumn vaccination programme
Novavax’s JN.1-adapted COVID-19 vaccine granted FDA emergency use authorisation
JN.1 only accounts for 0.2% of cases across the country but is the ‘parent strain’ of currently circulating variants
FDA approves updated COVID-19 vaccines to better protect against current variants
Adapted vaccines from Pfizer/BioNTech and Moderna have been authorised for individuals aged six months and older
JCVI announces advice for autumn COVID-19 vaccination programme eligibility
The Committee has advised offering the vaccine to those at high risk of serious disease
Pfizer/BioNTech’s Omicron JN.1-adapted COVID-19 vaccine approved by MHRA
The UK regulator has approved four versions of the updated vaccine for adults and children from infancy
ISID establishes six global infectious disease priorities to be addressed at 2024 congress
Involving health and community leaders, the ISID congress will commence in South Africa in December
Getting in-sync with Public Health at SYNC 2024
Medscape Education is bringing its public health efforts to Washington, DC for the SYNC conference on HIV, HCV, STIs, Harm Reduction, and LGBTQ health. During the conference, Lindsey will present...